Home / Recalls / Med Shop Total Care Inc. / D-0707-2021

D-0707-2021 Class I Terminated

Recalled by Med Shop Total Care Inc. — Longview, TX

Recall Details

Product Type
Drugs
Report Date
August 18, 2021
Initiation Date
October 5, 2020
Termination Date
August 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21 mL

Product Description

FENTANYL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 575MCG-18MG-6000MCG/ML, 21 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reason for Recall

Non-Sterility

Distribution Pattern

Texas and Puerto Rico

Code Information

Lot #: 09282020@75 BUD: 10/27/2020

Other recalls by Med Shop Total Care Inc.

  • D-0713-2021 Class I — MORPHINE-BUPIVACAINE-KETAMINE PF INJECTABLE 21 mL syringe in two strengths: a) 5 (October 5, 2020)
  • D-0709-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in (October 5, 2020)
  • D-0715-2021 Class I — MORPHINE-BUPIVACAINE-FENTANYL PF 30MG-15MG-2000MCG/ML INJECTABLE 21 mL syringe, (October 5, 2020)
  • D-0711-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-FENTANYL PF INJECTABLE 21 mL syringe in variou (October 5, 2020)
  • D-0708-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 21 mL syringes in vari (October 5, 2020)
  • D-0706-2021 Class I — FENTANYL-BUPIVACAINE HCL PF INJECTABLE 3000MCG-12MG/ML, 21 mL syringe, Rx only, (October 5, 2020)
  • D-0717-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL PF INJECTABLE 21 and 22 mL syringes in various (October 5, 2020)
  • D-0710-2021 Class I — MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes (October 5, 2020)
  • D-0716-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-SUFENTANIL PF 25MG-9MG-110MCG/ML INJECTABLE 21 (October 5, 2020)
  • D-0714-2021 Class I — SUFENTANIL-BUPIVACAINE-BACLOFEN PF 25MCG-12.5MG-750MCG/ML INJECTABLE 41 mL syrin (October 5, 2020)